Effects of Upper Extremity Flywheel Exercises on Skills, Muscle Oxygenation, and Fatigue in Adolescent Basketball (Flywheel)

January 11, 2026 updated by: Hüseyin Melih Göktuğ Akpulat, Istinye University

The Effects of Upper Extremity Flywheel Exercises on Athletic Skills, Muscle Oxygenation and Physical Fatigue in Adolescent Basketball Players

This study will investigate the effects of flywheel exercises targeting the upper extremities on athletic performance, muscle oxygenation, physical fatigue, and muscle strength in adolescent basketball players. A total of 36 healthy male adolescent basketball players aged 10-18 years will be included in the study and divided into two groups using stratified randomization: a flywheel exercise group (n=18) and a traditional strength training group (n=18).

Athletic skills will be assessed using the Johnson Basketball Skill Tests (passing test, dribbling test, shooting test), the Basketball Shooting Accuracy Test, and the Functional Shooting Performance Index (FAPI). Upper extremity muscle oxygenation will be measured using near-infrared spectroscopy (NIRS) with a Moxy muscle oxygen meter. Physical fatigue level will be determined using the Modified Borg Scale. Upper extremity muscle strength will be assessed using a Kinvent hand dynamometer and the Seated Single Arm Ball Throw Test. The flywheel group will undergo eccentric weight flywheel exercises three times a week for eight weeks. The traditional strength training group will follow a strength training program using dumbbells for the same duration and frequency. All assessments will be conducted before and after the training program.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Adolescence is a critical period in which athletic performance and musculoskeletal adaptations develop rapidly. In sports that actively utilize the upper extremities, such as basketball, strength, coordination, and fatigue tolerance directly affect performance. In recent years, flywheel exercise systems, which allow for eccentric loading, have emerged as an effective training method for improving muscle strength and neuromuscular adaptations. However, scientific evidence regarding the effects of these systems on adolescent athletes is limited. This study was planned to investigate the effects of flywheel exercises targeting the upper extremities on athletic performance, muscle oxygenation, and physical fatigue in adolescent basketball players. The study will be conducted using a randomized controlled design, with participants divided into two groups: a flywheel exercise group and a traditional strength training group. Both groups will receive a structured upper extremity strength training program of equal duration and frequency. Throughout the study, all participants will continue their routine basketball training; only the strength training method applied will differ between the groups. Assessments will be conducted before and after the training program, and intra-group and between-group changes will be analyzed. The findings are expected to provide important information about the applicability of flywheel exercises in adolescent athletes and their potential effects on performance.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
36

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Turkey (Türkiye)
      • Iğdır, Turkey (Türkiye), 76000
        • Recruiting
        • Iğdır Youth and Sports Provincial Directorate - Kazım Karabekir Sports Hall
        • Contact:
          • Iğdır Youth and Sports Provincial Directorate
          • Phone Number: 04762277991
          • Email: igdir@gsb.gov.tr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Volunteer male basketball players aged 10-18 who have played basketball for at least one year,
  • Who have regularly attended training sessions for the past 6 months,
  • Who do not have an injury that would restrict their participation in training will be included in the study.

Exclusion Criteria:

  • Those who have undergone upper extremity surgery within the last year
  • Those with neurological, cardiovascular, respiratory, or metabolic diseases (e.g., epilepsy, heart disease, asthma, diabetes, etc.)
  • Those who have sustained any upper extremity musculoskeletal injury within the last year

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Flywheel Training Group
Participants in this group will perform upper extremity eccentric-focused resistance training using a flywheel device. The training program will be conducted for 8 weeks, three sessions per week, in addition to regular basketball training.
Other: Flywheel Exercises
Participants perform 8 weeks of upper extremity eccentric resistance exercises using the flywheel device, 3 sessions per week, with progressive load increase over time.
Active Comparator: Traditional Resistance Training Group
Participants in this group will perform upper extremity resistance training using dumbbells. The training program will be conducted for 8 weeks, three sessions per week, with the same training frequency and duration as the flywheel group, in addition to regular basketball training.
Other: Traditional Resistance Training
Participants perform 8 weeks of upper extremity resistance exercises using dumbbells, 3 sessions per week, with individualized progressive load based on 1 repetition maximum (1RM).

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Basketball-Specific Skill Performance
Time Frame: Baseline and after 8 weeks of training
Basketball-specific skills will be assessed using the Johnson Basketball Skill Tests (passing, dribbling, and shooting tests), the Basketball Shooting Accuracy Test, and the Functional Throwing Performance Index (FTPI). Higher scores indicate better basketball-specific skill performance."
Baseline and after 8 weeks of training
Muscle Oxygenation
Time Frame: Baseline and after 8 weeks of training
Upper extremity muscle oxygenation will be assessed using near-infrared spectroscopy (NIRS) with a Moxy muscle oxygen monitor placed over the biceps brachii muscle during basketball-specific performance tasks. Higher oxygen saturation percentages indicate better muscle oxygenation.
Baseline and after 8 weeks of training
Physical Fatigue
Time Frame: Baseline and after 8 weeks of training
Perceived physical fatigue will be assessed using the Modified Borg Rating of Perceived Exertion (RPE) Scale, which ranges from 0 (no fatigue) to 10 (maximal fatigue). Higher scores indicate greater perceived physical fatigue.
Baseline and after 8 weeks of training

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Upper Extremity Isometric Muscle Strength
Time Frame: Baseline and after 8 weeks of training
Upper extremity isometric muscle strength will be assessed using a Kinvent handheld dynamometer. Measurements will include shoulder and elbow muscles. Strength will be recorded in kilograms or Newtons. Higher values indicate greater isometric strength.
Baseline and after 8 weeks of training
Upper Extremity Explosive Strength
Time Frame: Baseline and after 8 weeks of training
Upper extremity explosive strength will be evaluated using the Seated Single-Arm Medicine Ball Throw Test. Participants throw a medicine ball as far as possible from a seated position. Distance of the throw will be recorded in centimeters. Higher values indicate greater explosive strength.
Baseline and after 8 weeks of training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Istinye University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Huseyin Melih Goktug Akpulat, Istinye University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 21, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 1, 2025

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 31, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 14, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 29, 2025

First Posted (Estimated)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 9, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 13, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 11, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • IstinyeU-EC-25-117

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared due to the small sample size, the involvement of adolescent participants, and data protection and confidentiality considerations. Data will be used only for the purposes defined in the study protocol.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Fatigue

Clinical Trials on Flywheel Exercises

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings